Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

What to Expect from AMD Stock Ahead of Next Month’s Earnings Report

By Chris Lau, InvestorPlace Contributor

AMD stock could move any direction between now and when it reports quarterly earnings. Investors unsure of how things play out next should sit this one out.

Investors Should Buckle up for Another Potential Dip in Delta Air Lines Stock

By Chris Lau, InvestorPlace Contributor

Volatility will likely return for airline stocks as investors weigh in the risks of Covid-19 re-emerging in the United States

With an Extended 5G Rollout, Nokia Stock Looks Better Every Day

By Chris Lau, InvestorPlace Contributor

Nokia stock is forming a solid uptrend as it proves its 5G ambitions are paying off, as demonstrated with its customers.

7 Undervalued Stocks to Buy

By Chris Lau, InvestorPlace Contributor

Picking deep undervalued stocks will pay off in the long-run, as the economy takes its time to fully recover from the pandemic selloff.

Right Now, cbdMD Stock Is a Speculation That Could Pay off Big

By Chris Lau, InvestorPlace Contributor

Without a strong moat, YCBD stock is a risky stock yet it could double if it keeps cutting operating costs while growing revenue.

Load More